1. Delays in confirmatory trials for drug applications granted FDA’s accelerated approval raise concerns Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2022 Subject(s): Drug ApprovalLegislation, DrugUnited StatesUnited States. Food and Drug Administration
